AI Medical Imaging Platform Evaluation Guide 2026

Introduction

An AI medical imaging platform can flag urgent scans, measure anatomy, support interpretation, or route findings for follow-up. Yet a strong demonstration does not prove the software will work safely in your hospital. Performance can change with the patient population, scanner model, imaging protocol, or workflow.

This 2026 guide helps hospitals, radiology groups, imaging centers, and health plans evaluate medical imaging AI software beyond vendor claims. It covers intended use, regulatory status, clinical validation, PACS and RIS integration, DICOM, deployment, cybersecurity, monitoring, contracting, and pilot design. It also includes a procurement scorecard and risk checklist.

TL;DR: Buy for a defined clinical problem, then test the AI medical imaging platform with your own data and workflow. Use this guide for procurement and governance decisions. It does not provide medical advice.

Screenshot: FDA Artificial Intelligence-Enabled Medical Devices resource, captured July 2026. Buyers should verify the current authorization record for each product and intended use.

1. Define the Intended Use Before Comparing AI Medical Imaging Solutions

Start with the job. “Improve radiology” is too broad to evaluate. Instead, identify the patient group, modality, indication, user, output, and affected decision.

For example, a hospital might use AI to prioritize adult non-contrast head CT studies with suspected intracranial hemorrhage. That is different from software that detects hemorrhage, measures its volume, drafts a report, or sends an alert to a stroke team. Each use has different evidence, integration, and safety requirements.

Intended-use question	What the buyer should define	Example
Clinical problem	The delay, error, or workload issue	Long turnaround time for urgent head CT
Population	Age, setting, exclusions, and relevant demographics	Adults in the emergency department
Modality	CT, MRI, X-ray, ultrasound, mammography, or another format	Non-contrast head CT
Indication	The specific condition or finding	Suspected intracranial hemorrhage
Output	Alert, score, segmentation, measurement, or draft	Worklist-priority notification
User and action	Who receives the result and what they may do	Radiologist reviews the study sooner

Check modality fit closely. Do not assume an algorithm evaluated on standard chest radiographs works on portable images, pediatric studies, or different protocols. Likewise, CT software does not automatically cover MRI, and a model cleared for one anatomical region does not gain permission for another.

Useful real-world applications include:

• Prioritizing time-sensitive CT studies for radiologist review
• Acting as a second reader for mammography or chest X-ray
• Producing measurements or segmentations for treatment planning
• Finding incidental lung nodules and routing them to a follow-up program
• Checking image quality before a patient leaves the scanner

These remain different products when sold through one radiology AI platform. Evaluate every model and intended use separately.

2. Check Regulatory Status and Clinical AI Validation

In the United States, search the FDA AI-Enabled Medical Device List, then open the linked 510(k), De Novo, or premarket approval record. The FDA says its list identifies authorized devices that it has found, but it is not complete. More importantly, authorization applies to a particular device, version, intended use, and labeling. It does not clear the entire platform for every advertised task.

Record these details in the procurement file:

• Submission number and regulatory pathway
• Exact product and software version
• Indications for use and contraindications
• Required human oversight
• Supported modalities, acquisition protocols, and patient groups
• Whether the marketed feature matches the authorized feature
• Whether planned updates fall under an authorized change process

The FDA’s final 2025 guidance on predetermined change control plans addresses how certain planned modifications may be reviewed in advance. Still require notice of model, threshold, interface, and labeling changes.

Regulatory authorization neither proves local effectiveness nor replaces clinical AI validation. Ask for peer-reviewed studies, full study protocols, confidence intervals, subgroup results, and evidence from sites that were not involved in training. A systematic review of 86 radiology algorithms found reduced external-data performance in 81%. In 24%, the decrease was at least 0.10 on the reported unit scale. The Radiology: Artificial Intelligence review is a useful warning against accepting internal validation alone.

Compare the study population with your patients and scanners. Look for sensitivity, specificity, positive predictive value, negative predictive value, calibration, false alerts per study, and unreadable-study rates. Accuracy alone can hide clinically important errors.

3. Test PACS Integration, RIS, DICOM, and EHR Workflow

An accurate algorithm may add work by requiring another application. Before selecting software, map the path from image acquisition through PACS integration to clinical action.

The normal technical path may include:

1. A modality creates the study and sends it to the PACS or vendor-neutral archive.
2. A routing rule sends eligible images to the AI medical imaging platform.
3. The model processes the study and returns a result.
4. The PACS, RIS, worklist, or viewer displays the result in context.
5. The EHR records an alert, follow-up task, or clinical communication when needed.
6. Logs record delivery, review, acknowledgement, overrides, and failures.

DICOM is the international standard for medical images and related information. It supports storing, sending, querying, retrieving, and processing images across modalities, PACS, and other systems, according to the official DICOM overview. However, claimed DICOM support does not guarantee interoperability. Require the vendor’s DICOM Conformance Statement and test the services, transfer syntaxes, metadata, structured reports, segmentations, and secondary captures you will use.

Ask whether the platform supports:

• DICOM C-STORE, query/retrieve, DICOMweb, and required result objects
• HL7 v2 messages for orders, results, and patient updates
• FHIR APIs where the EHR workflow calls for them
• Single sign-on, role-based access, and audit logging
• Native PACS worklist changes rather than a separate dashboard
• Epic and Oracle Health integrations through supported interfaces rather than screenshots or manual copying

Integration claims should specify the tested PACS, RIS, EHR version, interface engine, and workflow. A connector used by another Epic or Oracle Health customer may still require local integration, configuration, and validation.

4. Compare Deployment and Cybersecurity for Radiology AI Platforms

Radiology AI platforms run in the cloud, locally, or through a hybrid design. No deployment model is universally best. Choose based on image volume, network capacity, downtime tolerance, security policy, and required speed.

Deployment	Advantages	Questions and tradeoffs
Cloud	Faster central updates and less local compute	Upload capacity, data location, outage behavior, and recurring processing costs
On-premises	Greater local control and lower dependence on external connectivity	Hardware cost, patching, capacity planning, and local support burden
Hybrid or edge	Local image processing with centralized management	More components, version coordination, and unclear support boundaries

Measure expected and peak study volume. Stroke triage may require results within minutes; retrospective incidental-finding searches may tolerate hours. Test large studies, simultaneous arrivals, planned maintenance, and loss of internet access. Define whether images queue, fail safely, or leave the AI workflow during outages.

A badge or hosting region does not establish HIPAA compliance. When a cloud provider creates, receives, maintains, or transmits electronic protected health information, HHS generally treats it as a business associate. The organization needs a business associate agreement and its own risk analysis, as explained in the HHS cloud-computing guidance.

Use this risk checklist before approving an AI medical imaging solution:

Risk area	What to check	Why it matters
Data use	Contractual limits on training, resale, and secondary use	A BAA alone may not settle every permitted use
Encryption	Encryption in transit and at rest, with documented key management	Imaging data contains sensitive identifiers
Access	SSO, least privilege, MFA, service-account controls, and access reviews	Shared or permanent credentials weaken accountability
Vulnerabilities	Software bill of materials, patch targets, penetration testing, and disclosure process	Unpatched components can expose PACS-connected systems
Incident response	Notification timing, investigation duties, evidence preservation, and contacts	Delayed reporting can worsen clinical and legal harm
Resilience	Backups, recovery objectives, failover, and tested downtime procedures	An alerting tool may become part of a time-sensitive workflow
Data lifecycle	Retention, deletion, export, subcontractors, and termination procedures	The hospital must know where every copy remains

NIST’s AI Risk Management Framework can help governance teams organize responsibilities for mapping, measuring, and managing AI risks. It does not replace healthcare law, regulatory review, or clinical governance.

5. Use a Weighted Procurement Scorecard and Strong Contract

A scorecard keeps polished demonstrations from outweighing weak evidence or difficult integration. Set the weights before receiving final proposals. Score each category from 0 to 5, apply its weight, and document the evidence.

Category	Weight	Evidence expected
Intended-use and modality fit	15%	Exact match to population, modality, indication, and workflow
Regulatory status	15%	FDA record or applicable local authorization for the proposed version and use
Clinical evidence	20%	External and prospective validation, subgroup results, and uncertainty intervals
Local performance plan	10%	Testable thresholds and access to case-level output
PACS, RIS, and EHR integration	15%	Conformance documents, architecture, interface scope, and tested workflow
Security and privacy	10%	BAA, risk documentation, audit results, access controls, and incident process
Operations and monitoring	10%	Uptime, support, version control, drift monitoring, and escalation procedures
Commercial terms	5%	Transparent total cost, exit rights, and data portability

Points elsewhere should not offset regulatory or patient-safety failures. Establish minimum gates for intended-use fit, authorization, security, and local validation before calculating the commercial score.

The contract should list every licensed model, site, modality, and version. It should also address:

• Setup responsibilities and acceptance criteria
• Interface, hosting, storage, support, and upgrade fees
• Uptime and response-time service levels
• Notification and approval rules for model changes
• Access to performance logs and case-level exports
• Security incidents, indemnity, insurance, and allocation of responsibility
• Restrictions on use of hospital data for model development
• Data return or deletion at termination
• Assistance and costs for switching platforms

My blunt view: an easy exit matters almost as much as an easy launch. AI medical imaging solutions change quickly. Proprietary formats, long auto-renewals, or vendor-dependent interfaces should not trap a hospital.

6. Run a Controlled Pilot With Predefined Metrics

A pilot validates the complete clinical AI system; it is not a product demonstration. Include radiology, the relevant clinical service, IT, security, privacy, compliance, quality, and operations. Name a clinical owner and an operational owner.

A practical pilot plan follows six steps:

1. Write the hypothesis. State the expected clinical or operational outcome. For example, the AI medical imaging platform will reduce the median time from scan completion to radiologist opening for eligible emergency head CT studies.

2. Set a baseline. Measure several weeks of volume, turnaround time, error rates, escalation patterns, and staffing. Account for shifts, weekends, sites, and case mix.

3. Validate silently first. Run the model in shadow mode without affecting care. Compare its outputs with final reports, expert review, or another predefined reference standard. Investigate disagreements instead of counting wins and losses.

4. Set thresholds before viewing results. Define acceptable sensitivity, false alerts per 100 studies, processing latency, technical failure rate, and subgroup performance. Include a stopping rule for unexpected harm or excessive alerting.

5. Conduct limited clinical use. Start with specific users, shifts, or sites. Train users on intended use, limitations, downtime, and how to report a questionable result.

6. Decide with evidence. Expand, require correction, extend the pilot, or stop. Record the decision and unresolved risks.

Track technical, clinical, workflow, and adoption metrics:

Pilot metric	Suggested measurement
Eligibility coverage	Eligible studies processed ÷ all eligible studies
Sensitivity and specificity	Results against the predefined local reference standard
Alert burden	False or non-actionable alerts per 100 processed studies
Latency	Median and 95th-percentile time from image availability to result delivery
Turnaround time	Baseline versus pilot, including median and 90th percentile
Technical reliability	Failed, delayed, duplicated, or mismatched results
User response	Result-view and acknowledgement rates, overrides, and survey findings
Equity	Performance by age, sex, race or ethnicity where appropriate, site, scanner, and care setting

A CT triage pilot should measure time to worklist review, not merely detection accuracy. A mammography second-reader pilot should study recall, cancer detection, reader workload, and arbitration. A chest X-ray quality tool should measure repeat imaging and technologist workflow. An incidental-nodule solution should measure completed follow-up, not the number of findings extracted. The metric must follow the intended action.

7. Plan Explainability, Monitoring, Drift, and Governance

Explainability should help the intended user act safely. A heat map may help one detection task but mislead another. Measurements, confidence values, source images, comparison data, or a traceable report sentence may be more useful. Ask what each explanation represents, how it was validated, and when it can be wrong.

Users also need practical information:

• What the medical imaging AI software is designed to detect or measure
• Which studies it excludes or cannot process
• Whether a negative result can safely change the normal review process
• How uncertainty and technical failure are displayed
• Who retains responsibility for the clinical decision
• How to report an apparent false result or unsafe behavior

Performance monitoring begins at launch. Scanner replacements, protocol or routing changes, population shifts, software updates, and compression can alter inputs. Drift may appear as changing sensitivity, alert prevalence, unreadable-study rates, or disagreement with radiology reports.

The American College of Radiology’s Assess-AI program describes monitoring model inputs, versions, and concordance with radiology reports. A local program should review those measures according to clinical risk.

Create an inventory containing the model owner, version, intended use, regulatory record, interfaces, validation date, monitoring thresholds, and retirement plan. Assign escalation levels for:

• A single questionable result requiring case review
• A recurring performance or routing problem
• A safety event requiring temporary suspension
• A vendor update requiring revalidation

Prohibit silent model updates. Even under an authorized change plan, require release notes, impact analysis, test results, deployment timing, rollback capability, and a local revalidation decision.

Conclusion

Choosing an AI medical imaging platform requires evidence, integration testing, and clinical AI validation, not a feature contest. Define one problem, then confirm the population, modality, indication, output, and user action. Then verify regulatory status, external evidence, local performance, DICOM behavior, PACS and EHR integration, security, and total cost.

A controlled pilot should measure patient-safety signals, technical reliability, workflow effects, subgroup performance, and alert burden against thresholds written in advance. After launch, maintain a model inventory, monitor drift, investigate failures, and revalidate meaningful changes.

Next, turn this scorecard and risk checklist into an organization-specific request for proposal. Require documents and testable commitments from vendors. Claims make a shortlist; evidence earns deployment.